RxDoctor Payments Data

Maria Sonnack

Medical · Iowa City, IANPI 1518366913

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Axsome Therapeutics, Inc. accounts for 69.2% of it on its own, with 19 other manufacturers making up the rest. Among medical clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$99,536in general payments, 2019–2025

Across 403 payments — averaging $246.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$69K
  • Otsuka America Pharmaceutical, Inc.$26K
  • Supernus Pharmaceuticals, Inc.$883
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$875
  • Brainsway USA Inc$859
  • AbbVie$536
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$38,75039%
  • Speaking & faculty fees$34,60135%
  • Travel & lodging$18,03718%
  • Food & beverage$8,1498%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$99,536 in reported general payments places this provider in the 95th percentile of 141 medical providers in Iowa.

See all medical providers in Iowa

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyvanseLisdexamfetamine Dimesylate13$4,958
Duloxetine Hcl14$221
Mirtazapine12$69

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$65$4,95813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 141 medical providers in Iowa.

Other medical in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →